Oncotelic Therapeutics, Inc. (OTLC) Net margin 2021–2024
Oncotelic Therapeutics, Inc. (OTLC) net profit margin by fiscal year — reported net income divided by reported revenue.
-11290.1%FY2024 · since FY2021: -545.9% → -11290.1%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | -11290.1% | — |
| FY2021 | -545.9% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More OTLC financial trends
OTLC RevenueOTLC Net incomeOTLC Gross profitOTLC Gross marginOTLC Operating incomeOTLC Operating marginOTLC Operating cash flowOTLC Free cash flowOTLC Capital expendituresOTLC Return on equityOTLC Stock buybacksOTLC Dividends paidOTLC Total assetsOTLC Total liabilitiesOTLC Shareholders’ equityOTLC overview →